期刊文献+

1-磷酸鞘氨醇后适应对大鼠心肌缺血/再灌注损伤的保护作用 被引量:11

Protective effect of sphingosine 1-phosphate postconditioning on myocardial ischemia reperfusion injury in rats
下载PDF
导出
摘要 目的观察1-磷酸鞘氨醇(sphingosine 1-phosphate,S1P)后适应对大鼠心肌缺血/再灌注损伤的保护作用。方法采用结扎冠状动脉左前降支(LAD)缺血30 min/再灌120 min的方法建立在体大鼠心肌缺血/再灌注损伤模型。60只大鼠随机分为5组(每组12只),即①假手术组(sham group);②缺血/再灌注组(I/R group);③S1P 0.5 mg·kg-1;④S1P 1 mg·kg-1;⑤S1P 2 mg·kg-1剂量组。四氮唑染色法观察心肌梗死面积;ELISA法测定血浆肌酸激酶同工酶(CK-MB)活性;比色法测定血浆丙二醛(MDA)、髓过氧化物酶(MPO)含量;光学显微镜及透射电子显微镜技术观察心肌组织形态学变化。结果与I/R组比较,S1P 0.5、1、2 mg·kg-1可降低心肌梗死面积(P<0.05),降低血浆CKMB活性(P<0.01)及MPO含量(P<0.05,P<0.01,P<0.01)。S1P 1、2 mg·kg-1可降低血浆MDA水平(P<0.01)。并可改善心肌坏死、炎细胞浸润、组织水肿以及线粒体损伤程度。结论 S1P后适应对大鼠心肌缺血/再灌注损伤具有保护作用,该作用可能与抑制炎症反应、拮抗氧化应激、保护线粒体结构功能有关。 Aim To study the protective effect of sphingosine 1-phosphate (SIP) postconditioning on myocardial ischemia/repeffusion injury in rats. Meth- ods Rat model of myocardial ischemia reperfusion in- jury was established by occluding the left anterior de- scending coronary artery for 30min then reperfusing for 120min. Sixty rats were randomly divided into 5 groups ( 12 rats in each group) : ( 1 ) sham group, (2) ischemia/reperfusion group ( I/R group), ( 3 ) S1P 0. 5 mg ·kg^-1,(4) SIP 1 mg ·kg^-1,and (5) SIP2 mg·kg^-1 group. The size of infarct area was determined by tetrazolium staining method. ELISA method was used to measure plasma CK-MB. Plasma MDA, MPO was measured by colorimetric method. To observe histomor- phology change of myocardium, light microscope and electron microscope were used. Results Compared with I/R group, SIP 0.5,1,2 mg ·kg^-1 could de- crease myocardial infarct size ( P 〈 0.05 ) , lower plas- maCK-MB (P 〈0.01) and MPO (P 〈0.05,P 〈 0.01,P〈0.01). SIP 1,2 mg ·kg^-1 could reduce plasma MPO ( P 〈 0. 01 ). Microscope study showed SIP could improve myocardial necrosis, and relieve neutrophil infilitration, tissue edema and mitochondrial damage. Conclusion SIP posteonditioning can pro- tect against myocardial ischemia/reperfusion injury, which may be related to the inhibition of inflammation, antioxidation, and mitochondrial protection.
出处 《中国药理学通报》 CAS CSCD 北大核心 2013年第10期1369-1373,共5页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No 81173058) 天津市自然科学基金资助项目(No 10JCZDJC20900)
关键词 1-磷酸鞘氨醇 心肌缺血 再灌注损伤 后适应 心肌梗死面积 心脏保护 sphingosine 1-phosphate myocardial is- chemia reperfusion injury postconditioning myocar- dial infarct size cardiopreteetion
  • 相关文献

参考文献4

二级参考文献64

  • 1王述昀,赵克森.血管通透性的调节和游离微血管技术在其研究中的应用[J].中国病理生理杂志,2005,21(1):203-208. 被引量:8
  • 2曹泽玲,杨庭树,龙超良,汪海.心肌缺血/再灌注损伤的内源性保护机制研究进展[J].中国药理学通报,2006,22(8):912-916. 被引量:29
  • 3Kadl A,Leitinger N.The role of endothelial cells in the resolution of acute inflammation[J].Antioxid Redox Signal,2005,7(11-12):1744-1754.
  • 4McVerry BJ,Garcia JG.Endothelial cell barrier regulation by sphingosine 1-phosphate[J].J Cell Biochem,2004,92(6):1075-1085.
  • 5Kendall S,Michel CC.The measurement of permeability in single rat venules using the red cell microperfusion technique[J].Exp Physiol,1995,80(3):359-372.
  • 6Lum H,Roebuck KA.Oxidant stress and endothelial cell dysfunction[J].Am J Physiol Cell Physiol,2001,280(4):C719-C741.
  • 7Yung LM,Leung FP,Yao X,et al.Reactive oxygen species in vascular wall[J].Cardiovasc Hematol Disord Drug Targets,2006,6(1):1-19.
  • 8Michel CC,Curry FE.Microvascular permeability[J].Physiol Rev,1999,79(3):703-761.
  • 9Bazzoni G,Dejana E.Endothelial cell-to-cell junctions:molecular organization and role in vascular homeostasis[J].Physiol Rev,2004,84(3):869-901.
  • 10Navarro P,Ruco L,Dejana E.Differential localization of VE-and N-cadherins in human endothelial cells:VE-cadherin competes with N-cadherin for junctional localization[J].J Cell Biol,1998,140(6):1475-1484.

共引文献42

同被引文献102

引证文献11

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部